Consequently, we speculated that if some factors can increase the permeability of the tumor cell membrane at the early stage of tumor development or metastasis, an intra-Ag-elicited humoral immune response or intra-Ag-specific mAbs will ensure anti-tumor therapeutic efficiency. The gene discussed is RENBP; the disease is neoplasm.